BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:21 PM
 | 
Nov 07, 2007
 |  BC Extra  |  Company News

LG, Gilead in caspase inhibitor deal

LG Life Sciences (Seoul, South Korea) granted GILD exclusive, worldwide rights, excluding Korea, China and India, to develop and commercialize LB84451 and other caspase inhibitors to treat fibrotic diseases....

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >